Johnson & Johnson vaccine trial halted by participant's illness
Johnson & Johnson has paused its COVID-19 vaccine study because one of its participants was taken ill.The 60,000-patient clinical trial met the criteria for a “pausing rule,” reported Stat News, meaning the online system that enrolls patients has been closed and the independent committee that monitors patient safety in the clinical trial will be convened.Johnson & Johnson confirmed that a document obtained by Stat News halting the trial did indicate the study was on hold, saying only that it was due to “an unexplained illness in a study participant,” without providing more detail, the news out...
New York Daily News
Fauci to FDA: 'I got your back' on COVID-19 vaccine safety standards
ATLANTA — The federal government’s top infectious disease official attempted to reassure the public Thursday that he’ll support safety standards set by federal officials for any COVID-19 vaccines and their work won’t be swayed by politics.“If (U.S. Food and Drug Administration officials) come and say this is the way we should do it, I’ve got your back on that,” Dr. Anthony Fauci said in an online discussion organized by Emory University.The remarks came in response to a question from Dr. Sanjay Gupta, an associate Emory University professor and CNN medical correspondent who moderated the discu...
The Atlanta Journal-Constitution
COVID vaccine trials lack important study participants
ATLANTA — Gwinnett County Transit driver Mikesha Walker talked to co-workers recently about whether they would participate in a COVID-19 vaccine research trial.They’re ideal participants, many researchers say. They spend more time with the public, which puts them at greater exposure to the disease. Many workers are Black, a demographic that is not adequately represented in trials.However, Walker said the drivers are very reluctant to participate. Many feel underappreciated and underpaid for continuing to work during the pandemic. They’re also aware of health studies done decades ago, such as t...
The Atlanta Journal-Constitution
Cuba is about to start testing its own COVID-19 vaccine, authorities say
MIAMI — Cuba will start testing its own COVID-19 vaccine candidate next week, according to the official Cuban registry of clinical trials.The vaccine, Soberana 01, was produced by the state-run Finlay Institute of Vaccines and will be tested during a phase I and II trial involving 676 adults between 19 and 80 years old. The results will not be published until February 2021.A phase I clinical trial evaluates a drug’s side effects and toxicity. If the results are good, the process can continue to a phase II trial to determine if the medication works.It’s unclear if a late-stage, phase III trial,...
COVID-19 vaccine trial kicks off in Florida, with volunteers getting up to $1,000
FORT LAUDERDALE, Fla. — Another major clinical trial is underway in the global race for a COVID-19 vaccine — with researchers this time planning to pay participants hundreds of dollars in Palm Beach County.The experimental vaccine, called AZD1222, was developed by AstraZeneca in conjunction with the University of Oxford. The drug arrived Monday morning to the campus of the JFK Medical Center in Atlantis, and the first 10 patients for the study will start the process Tuesday morning. The vaccine is one of just five that are in the crucial stage of Phase 3 testing, according to Dr. Larry Bush, l...
A coronavirus vaccine is on the horizon, thanks to a key discovery by these researchers
AUSTIN, Texas — When the latest coronavirus emerged, Jason McLellan and his team were ready to take action.McLellan, an associate professor of molecular biosciences at the University of Texas, has been studying respiratory diseases for years. In 2017, McLellan’s postdoctoral researcher Nianshuang Wang identified genetic mutations necessary to stabilize a key component of diseases like MERS, also a coronavirus.So when Chinese researchers shared the genetic sequence of the new coronavirus on Jan. 10, UT researchers were able to quickly map the virus and inject it with previously-discovered mutat...